Default company panoramic image

All Clear Diagnostics, Inc. (ACDx)

ACDx is a disruptive solution solving MRI unmet needs for cardiac, vascular and neurological gating issues, providing patient safety monitoring during exams.

  • Stage Product In Development
  • Industry Medical Devices and Equipment
  • Location San Francisco, CA, USA
  • Currency USD
  • Founded April 2012
  • Employees 5
  • Incorporation Type C-corp
  • Website

Company Summary

All Clear Diagnostics - comprised of professional medical, technical and IT personnel. ACDx is a disruptive AI-enhanced, patented solution meeting MRI customer needs for: 1) diagnostic-quality ECG monitoring during procedures, 2) blood-flow metrics, 3) reduced test times up to 50% and 4) enhanced decision support and 5) Big Data applications. Our goal is to gain market share by providing advanced capabilities at competitive prices.


  • Default avatar
    James Guzzetta
    President - CEO

    Mr. Guzzetta is a vision-oriented, self-driven technology innovation professional with nearly thirty five (35) years of experience in IT and Health/IT. As founder, he brings strategic planning, organizational and team development as well as systems architecture skills, team leadership and experience. He is co-author of four medical device and method patents.
    Mr. Guzzetta has led large-scale, complex projects across multiple industries.

  • Default avatar
    Steven Wolff
    EVP - CTO

    Mr. Wolff brings over thirty (30) years experience managing highly diverse technical teams in technology and ECG medical device development. As a co-founder, he has helped to evolve ACDx’s technology strategy, including design specifications and use-case analyses. He holds degrees in Mechanical & Electrical Engineering, and is author of 11 patents on microphone and speech technologies and co-author of 4 MGI technology patents.

  • Default avatar
    Justin D. Pearlman
    Chief Medical Officer

    Dr. Pearlman is a world-renowned Cardiologist specializing in advanced imaging methods. He holds numerous patents in medical imaging, a tenured Professor of Radiology and Medicine from Harvard University and M.I.T. Dr. Pearlman’s “Multivariate Signal Separation” IP is under exclusive world-wide license by ACDx. He is Chief of Medicine at Kern Hospital (a UCLA affilitate) and formerly, Director of Adv Cardiovascular Imaging at Dartmouth-Hitchcock

  • Default avatar
    Mark Donaghy

    Mr. Donaghy is an intuitive, results-driven leader with expertise in financial institution operations and finance and corporate development. Ability to envision and create successful outcomes in complex situations. Diverse financial institution expertise, with a tenacious commitment to driving improvements, profit and market share growth while managing risk and stakeholders. Formerly SciAn, Deloitte & Touche, Advanced Financial Concepts

  • Default avatar
    Glen Williams
    Principal Engineer

    Glen comes to the Company from MedRad, which, prior to the Bayer acquisition, positioned their Veris device as the #2 MRI Gating system in the market. Glen was key in developing Veris software and hardware and is now a key member of our R&D team. Glen is a physicist and mathematician with a major contribution to ACDx capabilities.


  • Default avatar
    Wilson Sonsini
    29a58716 571b 453e aa52 d04cbe6cbd21
    Business Advisor - Presidient VitalHealth Software, formerly GE Healthcare
    Default avatar
    Dr. William Bradley
    Director of Radiology - UCSD Medical Center

Previous Investors

  • Default avatar
    Default avatar
    Friends & Family